#LXM5

top of page

Use tab to navigate through the menu items.

Use tab to navigate through the menu items.

Laxxon's New Generation Levodopa/Carbidopa Treatment, LXM.5, Granted Funding by ESF Plus and the Free State of Thuringia

Laxxon's New Generation Levodopa/Carbidopa for Parkinson's Disease project, LXM.5, has been awarded a grant.

Feb 112 min read

Innovate with Us

261 Madison Ave
New York, NY 10016

Subscribe for updates on our latest developments.

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

Thanks for submitting

Subscribe for updates on our latest developments.

Thanks for submitting!

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

Thanks for submitting!

bottom of page